Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Biomaterials. 2019 Jun 20;217:119291. doi: 10.1016/j.biomaterials.2019.119291

Figure 2.

Figure 2.

An illustration of representative non-viral biomaterials (outer circle) together with versatile RNA therapeutics (inner circle) that have been exploited for treating genetic and rare diseases (GARDs). [9, 37–49]